Acutronic Medical Systems AG
Beschreibung
ACUTRONIC Medical Systems AG develops, manufactures, and distributes high-tech ventilation and monitoring solutions for neonatal, paediatric and adult ICUs and intensive care transportation. It is part of the Vyaire Medical group which has a global workforce of more than 4´000, operating facilities around the world to manufacture and market more than 27,000 unique products for the diagnosis, treatment and monitoring of respiratory conditions in every stage of life.
Leaders in technology since 1981.
ACUTRONIC Medical Systems AG was founded 1981 in Hirzel, Switzerland. We first gained worldwide attention for our jet ventilation products – a specifically assigned method of artificial respiration in ENT and thoracic surgery. Being the driving force behind the Foundation of the European Society for Jet Ventilation, we had already recognized the importance of developing new ways of artificial respiration technologies for high risk patients.
Distributing worldwide.
Today, ACUTRONIC is a privately-held company developing, manufacturing and distributing high tech ventilation and monitoring solutions for NICUs/PICUs, ICUs and intensive care transportation in over 90 countries. We are the leading partner for hospitals when it comes to the most critical areas of respiratory care: neonatalogy/pediatrics, jet ventilation and difficult airway management.
Forward thinking.
It is our aspiration to develop innovative solutions that simplify the busy clinical routine for caregivers and increase the safety of patients. With over 30 years of experience and together with our global network of clinical experts, we are quickly able to translate new developments into real innovations – and keep challenging ourselves to improve and set standards in the market continuously.
Exploring where others stop.
ACUTRONIC products have won an excellent reputation for precision, quality and service in the industry. We strive every day to provide the technologically best solutions that are needed for the most medically challenging groups of patients. We continuously explore where others stop.